Closed System Transfer Device Market Size, Share, Analysis, Trends, Growth, 2032

Closed System Transfer Device Industry Prospective:

The global closed system transfer device market size was evaluated at $1,272.33 million in 2023 and is slated to hit $3,825.12 million by the end of 2032 with a CAGR of nearly 13.01% between 2024 and 2032.  

Request Free Sample

Closed System Transfer Device Market: Overview

A closed system transfer device also referred to as a closed system drug transfer device is a device used for transferring medicine in a way prohibiting the transfer of contaminants/pollutants from the atmosphere into a system. Reportedly, this closed system transfer equipment prevents the uncontrolled inflow as well as the outflow of pollutants & drugs, thereby maintaining the solution quality that can be infused into a subject.

Key Insights

• As per the analysis shared by our research analyst, the global closed system transfer device market is projected to expand annually at the annual growth rate of around13.01% over the forecast timespan (2024-2032)
• In terms of revenue, the global closed system transfer device market size was evaluated at nearly $1,272.33 million in 2023 and is expected to reach $3,825.12 million by 2032.
• The global closed system transfer device market is anticipated to grow rapidly over the forecast timeline owing to a prominent increase in the approval of drugs for treating cancer and surging know-how related to the benefits of using closed system transfer devices.
• In terms of type, the membrane-to-membrane segment is slated to register the highest CAGR over the forecast period.
• Based on technology, the diaphragm-based devices segment is predicted to contribute majorly towards the global industry revenue in the upcoming years.
• Based on component, the vial access device segment is predicted to lead the segmental surge in the upcoming years.
• Based on end-user, the hospital & clinics segment is predicted to contribute leading the segmental space in the years ahead.
• Region-wise, the North American Closed System Transfer Device industry is projected to register the fastest CAGR during the projected timespan.

Request Free SampleClosed System Transfer Device Market: Growth Factors

Rise in the rate of drug approvals can prompt the growth of the market globally

A prominent increase in the approval of drugs for treating cancer and surging know-how related to the benefits of using closed system transfer devices is anticipated to boost the growth of the global closed system transfer device market. Apparently, technological breakthroughs in closed-system transfer devices are predicted to embellish the expansion of the global market. The escalating requirement of transporting antineoplastic or cytotoxic medicines is projected to embellish the expansion of the market globally.

A rise in the occurrence of chronic disorders such as cancer, stroke, and heart disorders will proliferate the growth of the global market. Apart from this, a surge in the occurrence of lung ailments such as kidney ailments as well neurological disorders such as Parkinson's disease and Alzheimer’s disease can pave the way for huge growth of the market across the globe.

Closed System Transfer Device Market: Restraints

Humungous costs of implementing closed system transfer devices can restrict the global industry surge by 2032

Surging prices of executing closed system transfer equipment increase medical treatment costs, thereby posing a huge threat to the expansion of the global closed system transfer device industry.

Closed System Transfer Device Market: Opportunities

Escalating awareness about occupational risks of exposure of patients to drugs can open new growth opportunities for the global market

Growing consciousness about occupational hazards among the end-users can open new facets of growth for the global closed system transfer device market. The need for complying with strict regulations pertaining to drug approvals can open new avenues of growth for the global market.

Closed System Transfer Device Market: Challenges

Incompatibility of drugs with the closed system transfer deice can prove a huge challenge for the global industry expansion

Issues of compatibility and product standardization can pose a huge challenge to the growth of the global closed system transfer device industry.

Closed System Transfer Device Market: Segmentation

The global closed system transfer device market is divided into type, technology, component, end-user, and region.                                         

In type terms, the closed system transfer device market across the globe is bifurcated into membrane-to-membrane and needleless segments. Additionally, the membrane-to-membrane segment, which acquired nearly 36%of the global market revenue in 2023, is expected to record the fastest annual rate of growth in the forecast timespan. The expansion of the segment in the next eight years can be due to substantial breakthroughs in membrane-to-membrane systems which ensure safe & effective transfer of fluids & drugs and hence have large acceptance in the healthcare sector.

Based on the technology, the global closed system transfer device industry is sectored into air cleaning/filtration devices, diaphragm-based devices, and compartmentalized devices segments. Additionally, the diaphragm-based devices segment, which garnered about 63% of the global industry revenue in 2023, is expected to make notable contributions towards the global industry share over the analysis timeframe. The growth of the segment in the forthcoming years can be due to the outstanding performance of diaphragm-based devices in assuring safe and effective transport of sensitive medicines and fluids. Furthermore, these systems are easy to handle and reliable as compared to other systems.

On the basis of components, the closed system transfer device industry across the globe is segregated into bag spike, vial access device, female component, and male luer segments. Furthermore, the vial access segment, which dominated the segmental surge in 2023, will continue its segmental domination in the upcoming years. The segmental surge over 2024-2032 can be due to its key role in assuring the safety of drug transfer methods along with reducing contamination risk.

Based on the end-user, the closed system transfer device industry across the globe is divided into oncology centers and hospitals & clinics segments. Moreover, the hospitals & clinics segment, which accounted lucratively towards the global industry size in 2023, will drive the segmental surge in the ensuing years. The segmental expansion in the next few years can be due to hospitals & clinics being key point-of-care locations for patients. Moreover, closed system transfer equipment is utilized in hospitals & clinics to prevent exposure of patients to hazardous medicines along with avoiding contamination.

Closed System Transfer Device Market: Report Scope

Closed System Transfer Device Market: Regional Insights

North America is expected to maintain the leading status in the global market in the upcoming years

North America, which accounted for nearly 70% of the global closed system transfer device market revenue in 2023, is expected to establish its dominant status in the global market in the years to come. In addition to this, the regional market growth in the next few years can be due to technological innovations, the presence of strong healthcare infrastructure, and the execution of strict regulatory frameworks in countries such as Canada and the U.S. High healthcare spending and safe healthcare practices will drive the regional market trends.

Asia-Pacific's closed system transfer device industry is anticipated to register the fastest growth rate in the forecast timespan. The expansion of the industry in the region over forecasting years can be attributed to the presence of key players in the Asia countries. Apart from this, improvement witnessed in the healthcare facilities of the region along with surging investment made by key product manufacturers in research & development programs for introducing new products with beneficial features can boost the industry growth in the region.

Key Developments

• In the first half of 2018, Baxter introduced arisure closed system transfer equipment for preventing harmful drug exposure along with maintaining steadiness of medication.

Closed System Transfer Device Market: Competitive Space

The global closed system transfer device market profiles key players such as:

• Baxter International Inc.
• Yukon Medical
• ICU Medical Inc.
• Equashield
• Becton
• Dickinson and Company
• CodanMedizinischeGeräte GmbH & Co Kg
• Braun Melsungen
• Teva Pharmaceutical Industries Ltd.
• Corvida Medical
• Victus Inc.

The global closed system transfer device market is segmented as follows:

By Type

• Membrane-to-Membrane
• Needleless

By Technology

• Air Cleaning/Filtration Devices
• Diaphragm-Based Devices
• Compartmentalized Devices

By Component

• Bag Spike
• Vial Access Device
• Female Component
• Male Luer

By End-User

• Oncology Center
• Hospitals & Clinics

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa